# Exploring Microalgae as a Novel Resource for Hepatocellular Carcinoma Therapy

## TL;DR

This paper explores the potential of microalgae as a new source of cancer treatments, focusing on their use in fighting hepatocellular carcinoma.

## Contribution

The paper introduces microalgae as a novel platform for developing next-generation cancer therapeutics, particularly for hepatocellular carcinoma.

## Key findings

- Microalgae produce anticancer metabolites and have photosensitizing activity useful for cancer therapy.
- Preclinical studies show microalgae have significant potential as chemopreventive agents against HCC.
- Future strategies include using biotechnology to enhance microalgal bioactive compound production for drug delivery.

## Abstract

Hepatocellular carcinoma (HCC) remains a major cause of cancer-related mortality in the world. Although there is an armamentarium of therapeutic options available for HCC therapy, current treatment modalities still face challenges, such as limited effectiveness and resistance to therapy due to inherent intratumoral heterogeneity. Hence, the development of novel therapeutics is an unmet need. Microalgae possess the ability to provide naturally derived compounds that are attractive for biomedical applications. The multifunctional nature of microalgae, with its unique combination of anticancer metabolites, oxygen-generating capability, and photosensitizing activity, make them a versatile platform for developing next-generation cancer therapeutics. In light of the above, this succinct narrative review highlights the potential biomedical applications of microalgae in cancer therapy, with a focus on HCC. Preclinical studies have shown the significant potential of microalgae as naturally occurring sources of chemopreventive and anticancer agents against HCC. Future directions include the use of biotechnology to enhance the production of microalgal-derived bioactive compounds and the formulation of biocompatible and biodegradable drug–microalgae embolic agents with prolonged release of anticancer drugs, thereby giving rise to synergistic antitumor effects, and their application for the delivery of immune checkpoint inhibitors for immunotherapy in HCC. Overall, microalgae hold considerable promise for advancing innovative therapeutic strategies against HCC.